Phoenix Bioscience Core Unveils XLR8 PBC to Propel Scale-Ready Health Tech Companies

The Phoenix Bioscience Core (PBC) is excited to announce applications are now open for XLR8 PBC, taking place in Phoenix April 8-17, 2025. This intensive 8-day in-person program is designed for scale-ready health tech companies. XLR8 PBC helps participants secure appropriate capital, connect with experienced growth-stage executives, and establish corporate partnerships that validate market fit. During their time at PBC, companies also will have access to innovative collaboration spaces, student analysts, and a supportive ecosystem dedicated to enhancing growth potential.

“XLR8 PBC is a one-of-a-kind program that fills a critical gap in Arizona and the region,” said Brian Ellerman, Executive Director of XLR8 PBC. “We designed this to support and enhance the success of scale-ready companies, providing them with the unique resources and connections they need to thrive in the competitive health tech industry.” 

XLR8 PBC is focused on scaling health tech companies from virtual care, digital health, payor tech, provider tech, medical devices, and health & wellness, ensuring that participants are well-positioned for growth. At this time, the program cannot support pre-approval devices or therapeutics. But for post-approval or non-regulatory health tech companies ready to scale, XLR8 PBC offers an unparalleled opportunity to accelerate their journey. 

To learn more and determine if your company meets the criteria, visit XLR8 PBC. By joining, companies can leverage the unique resources and collaborative environment of the Phoenix Bioscience Core, positioning themselves for significant growth and success in the health tech industry.

About the Phoenix Bioscience Core

The Phoenix Bioscience Core (PBC) is a 30-acre life sciences innovation district located in downtown Phoenix. It hosts Arizona’s three public research universities—Arizona State University, Northern Arizona University, and the University of Arizona—as well as leading genomics pioneers like the Translational Genomics Research Institute (TGen), part of the City of Hope, and the International Genomics Consortium. The PBC also collaborates with major healthcare systems, including Banner Health, Phoenix Children’s Hospital, Dignity Health, HonorHealth, Phoenix VA, and Valleywise Health, alongside a growing number of emerging life science companies. This unique concentration of research scientists and healthcare professionals fosters unprecedented collaborations, advancing precision medicine from discovery to delivery. To learn more, please visit phoenixbiosciencecore.com.


Read Next:

PBC Arts Committee Student Grant to showcase student research and innovation through art
The Phoenix Bioscience Core Arts Committee is excited to announce a student grant opportunity!  This program will award funds of …
Ten Arizona research teams earn $100K Flinn Foundation seed grants
The Flinn Foundation Seed Grants to Promote Translational Research program has awarded a combined $1 million to 10 Arizona …
Unlocking the immune system’s potential to fight skin cancer
Karen Hastings, MD, PhD, is exploring how neoantigens can be used as a target for vaccines to help fight …